Ichikawa, Japan

Jun Nagura

This inventor holds 2 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1995-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Nagura. Retrieved from https://idiyas.com/inventor/jun-nagura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jun Nagura: Innovator in Cerebral Circulation

Introduction

Jun Nagura is a notable inventor based in Ichikawa, Japan. He has made significant contributions to the field of cerebral circulation, holding a total of 2 patents. His work focuses on innovative methods to improve cerebral blood flow, which is crucial for brain health.

Latest Patents

Nagura's latest patents include a method of ameliorating cerebral circulation. This invention features an ameliorant that contains 2-carbamoyloxymethyl-4-(2,3-dichlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3-isopropyl ester 5-methyl ester as an active ingredient. Another significant patent is the ameliorant of cerebral circulation and optical isomer of NB-818, which also utilizes the same active ingredient to enhance cerebral circulation.

Career Highlights

Jun Nagura is associated with Banyu Pharmaceutical Co. Ltd., where he continues to innovate in the field of pharmaceuticals. His work has the potential to impact the treatment of various conditions related to cerebral circulation.

Collaborations

Some of his notable coworkers include Masaru Nishikibe and Kazuo Kamei, who contribute to the collaborative efforts in research and development at Banyu Pharmaceutical.

Conclusion

Jun Nagura's contributions to cerebral circulation through his patents highlight his role as an important inventor in the pharmaceutical industry. His innovative approaches may lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…